An Israeli start-up based in Caesarea found a completely new approach to fighting tumors. No wonder, it didn't take long to be found by investors. The fight against cancer mobilizes millions. Read more on VonNaftali: Subscription $29,90/12 months (net). IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) develops and markets ProSense®, an advanced liquid-nitrogen-based cryoablation therapy … Continue reading Freeeeze: Israeli Start-up Against Cancer raised $14,5 Million →